We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$14.9B
AUM Growth
+$995M
(+7.2%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$128M |
| 2 |
LTHM
Livent Corporation
LTHM
|
+$15M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$12.3M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$12.2M |
| 5 |
P
Everpure Inc
P
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$28.4M |
| 2 |
Microsoft
MSFT
|
+$25.6M |
| 3 |
NVIDIA
NVDA
|
+$15.2M |
| 4 |
Amazon
AMZN
|
+$11.2M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.53% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 11.68% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Extreme Networks
EXTR
$3.16B
| $730K | ﹤0.01% |
63,261
-3,609
| -5% | -$49.2K |
|
1477
John Wiley & Sons Class A
WLY
$2.63B
| $730K | ﹤0.01% |
19,140
| – | – |
|
1478
News Corp Class B
NWS
$17.7B
| $727K | ﹤0.01% |
26,877
-1,020
| -4% | -$27K |
|
1479
Goosehead Insurance
GSHD
$2.33B
| $722K | ﹤0.01% |
10,843
-556
| -5% | -$42.5K |
|
1480
MGP Ingredients
MGPI
$381M
| $721K | ﹤0.01% |
8,371
| – | – |
|
1481
Magnite
MGNI
$3.49B
| $721K | ﹤0.01% |
67,026
-3,647
| -5% | -$36.4K |
|
1482
Jack in the Box
JACK
$358M
| $720K | ﹤0.01% |
10,521
| – | – |
|
1483
Utz Brands
UTZ
$1.25B
| $720K | ﹤0.01% |
39,064
| – | – |
|
1484
Mercury Insurance
MCY
$5.84B
| $720K | ﹤0.01% |
13,960
| – | – |
|
1485
Recursion Pharmaceuticals
RXRX
$1.78B
| $719K | ﹤0.01% |
72,161
| – | – |
|
|
UNIT
1486
Uniti Group
UNIT
$2.31B
| $717K | ﹤0.01% |
121,527
-3,289
| -3% | -$18.8K |
|
1487
ADMA Biologics
ADMA
$2.11B
| $716K | ﹤0.01% |
108,459
-2,007
| -2% | -$11K |
|
1488
Krispy Kreme
DNUT
$569M
| $710K | ﹤0.01% |
46,589
| – | – |
|
1489
Green Plains
GPRE
$1.09B
| $709K | ﹤0.01% |
30,687
| – | – |
|
1490
HEICO Corp Class A
HEI.A
$38B
| $708K | ﹤0.01% |
4,600
+14
| +0.3% | +$2.07K |
|
1491
RB Global
RBA
$16B
| $707K | ﹤0.01% |
9,283
+28
| +0.3% | +$1.96K |
|
1492
Intapp
INTA
$3.05B
| $706K | ﹤0.01% |
20,591
+5,829
| +39% | +$229K |
|
|
LTC
1493
LTC Properties
LTC
$2.1B
| $705K | ﹤0.01% |
21,691
| – | – |
|
1494
First Commonwealth Financial
FCF
$2.18B
| $705K | ﹤0.01% |
50,631
-2,823
| -5% | -$39K |
|
1495
Northwest Natural Holdings
NWN
$2.12B
| $705K | ﹤0.01% |
18,928
| – | – |
|
1496
Sarepta Therapeutics
SRPT
$1.95B
| $704K | ﹤0.01% |
5,440
+17
| +0.3% | +$2.08K |
|
|
NVEE
1497
DELISTED
NV5 Global
NVEE
| $704K | ﹤0.01% |
28,736
| – | – |
|
1498
National Bank Holdings
NBHC
$1.94B
| $703K | ﹤0.01% |
19,494
| – | – |
|
1499
Icon
ICLR
$12.9B
| $703K | ﹤0.01% |
2,092
+6
| +0.3% | +$1.77K |
|
1500
Qiagen
QGEN
$8.93B
| $702K | ﹤0.01% |
15,925
-39
| -0.2% | -$1.78K |
|
Similar funds
BA
FAM
VARA
CHP
MIC
OAG
MetLife Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
- MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
- MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
- MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
- MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
- MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.
Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.